Purchases and Sales Made in Q2 2023 in Genetic Technologies LTD (GENE)
This table provides information about the institutional ownership of Genetic Technologies LTD (GENE) during Q2 2023. The information is specifically focused on institutions that hold shares of GENETIC TECHNOLOGIES LTD.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 08, 2023
Q2 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
18.7KNew |
$15K - $21.1K
|
18.7K
$14.4K
|
|
Aug 14, 2023
Q2 2023
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
4.63K+ 45.08% |
$3.71K - $5.23K
|
14.9K
$11.5K
|
|
Jul 27, 2023
Q2 2023
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
2.32K+ 14.61% |
$1.85K - $2.62K
|
18.2K
$14K
|
|
Jul 11, 2023
Q2 2023
|
Gradient Investments LLC
|
BUY
|
- |
2.19KNew |
$1.75K - $2.48K
|
2.19K
$1.69K
|
|
Aug 04, 2023
Q2 2023
|
Simplex Trading, LLC
|
BUY
|
- |
444+ 210.43% |
$355 - $502
|
655
$504
|
|
Aug 03, 2023
Q2 2023
|
New Square Capital LLC
|
BUY
|
- |
100New |
$80 - $113
|
100
$77
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
SELL
|
- |
-3.55K- 97.26% |
$2.84K - $4.01K
|
100
$77
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-13.7K- 13.44% |
$11K - $15.5K
|
88.4K
$68K
|